Numerous widely used chemicals induce genetic and epigenetic alterations implicated in various diseases, including cancer.

A noninvasive clinicopathologic and gene expression profiling (CP-GEP)–based tool, the Merlin assay, shows promise for ...

is an assay used for fluorescent imaging of RNA targets in formalin-fixed, paraffin-embedded tissue samples. By integrating the Los Angeles-based company’s assay with the BOND RX and BOND RXm ...

Tissue samples were analysed using the Tempus xT tumour normal assay, an NGS-based cancer genome profiling test that interrogates 648 cancer-related genes in tumour tissue with a matched normal ...

protein interactions and protein modifications in fixed cells and tissue samples. The Duolink ® immunoassay reagents are based on the in situ proximity ligation assay, capable of reporting ...

The firm's next-generation sequencing-based test detects single nucleotide variants, insertions, and deletions in 22 genes.

Biocartis Announces Launch of the Brand-New Idylla™ POLE-POLD1 Mutation Assay . Mechelen, Belgium, 02 April 2025 – Biocartis NV (“Bioca ...

Angle updates on AstraZeneca development work and Eisai’s phase 2 pilot study: London Tuesday, March 25, 2025, 11:00 Hrs [IST] Angle Inc, a world-leading liquid biopsy company w ...